Skip to main content

Featured

Lawyers Demand Justice After Quebec Teen’s Death

Lawyers representing the family of Nooran Rezayi , a 15-year-old boy fatally shot by police in Longueuil, Quebec, are calling for accountability after allegations of interference in the investigation. Rezayi was killed on September 21, 2025 , in a suburban neighborhood south of Montreal. Quebec’s police watchdog (BEI) has accused local officers of questioning witnesses and attempting to obtain video footage , actions that could compromise the independence of the probe. Lawyers for Rezayi’s family insist such interference cannot go unpunished. The family has filed a $2.2 million lawsuit against the Longueuil police and the city, claiming “unreasonable and disproportionate force” was used against the unarmed teen. His mother, Fahima Rezayi, has urged authorities to ensure accountability, stressing that “this must never happen again.” The case has sparked outrage and renewed calls for reform in Quebec’s policing system. Critics argue that protecting the watchdog’s independence is ess...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment